X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Pfizer with Abbott India - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PFIZER vs ABBOTT INDIA - Comparison Results

PFIZER    Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

ABBOTT INDIA 
   Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PFIZER ABBOTT INDIA PFIZER/
ABBOTT INDIA
 
P/E (TTM) x 32.8 38.7 85.0% View Chart
P/BV x 4.9 11.2 43.7% View Chart
Dividend Yield % 0.8 0.5 141.2%  

Financials

 PFIZER   ABBOTT INDIA
EQUITY SHARE DATA
    PFIZER
Mar-17
ABBOTT INDIA
Mar-17
PFIZER/
ABBOTT INDIA
5-Yr Chart
Click to enlarge
High Rs2,0555,190 39.6%   
Low Rs1,6514,351 37.9%   
Sales per share (Unadj.) Rs429.81,382.9 31.1%  
Earnings per share (Unadj.) Rs73.6130.2 56.5%  
Cash flow per share (Unadj.) Rs87.4137.9 63.3%  
Dividends per share (Unadj.) Rs20.0040.00 50.0%  
Dividend yield (eoy) %1.10.8 128.7%  
Book value per share (Unadj.) Rs528.7652.7 81.0%  
Shares outstanding (eoy) m45.7521.25 215.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.33.4 125.0%   
Avg P/E ratio x25.236.6 68.7%  
P/CF ratio (eoy) x21.234.6 61.3%  
Price / Book Value ratio x3.57.3 48.0%  
Dividend payout %27.230.7 88.4%   
Avg Mkt Cap Rs m84,777101,373 83.6%   
No. of employees `0002.83.1 92.1%   
Total wages/salary Rs m3,0393,453 88.0%   
Avg. sales/employee Rs Th6,925.99,531.9 72.7%   
Avg. wages/employee Rs Th1,070.41,119.9 95.6%   
Avg. net profit/employee Rs Th1,186.3897.3 132.2%   
INCOME DATA
Net Sales Rs m19,66329,387 66.9%  
Other income Rs m1,012576 175.5%   
Total revenues Rs m20,67429,963 69.0%   
Gross profit Rs m3,4913,973 87.9%  
Depreciation Rs m629164 383.0%   
Interest Rs m1020 47.1%   
Profit before tax Rs m3,8644,365 88.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m1,3040-   
Tax Rs m1,8011,598 112.7%   
Profit after tax Rs m3,3682,767 121.7%  
Gross profit margin %17.813.5 131.3%  
Effective tax rate %46.636.6 127.3%   
Net profit margin %17.19.4 181.9%  
BALANCE SHEET DATA
Current assets Rs m20,78918,906 110.0%   
Current liabilities Rs m7,8706,297 125.0%   
Net working cap to sales %65.742.9 153.1%  
Current ratio x2.63.0 88.0%  
Inventory Days Days6062 96.1%  
Debtors Days Days2222 103.6%  
Net fixed assets Rs m9,1751,159 791.8%   
Share capital Rs m458213 215.3%   
"Free" reserves Rs m23,73113,657 173.8%   
Net worth Rs m24,18913,869 174.4%   
Long term debt Rs m250-   
Total assets Rs m32,70620,638 158.5%  
Interest coverage x403.5215.0 187.7%   
Debt to equity ratio x00-  
Sales to assets ratio x0.61.4 42.2%   
Return on assets %10.313.5 76.5%  
Return on equity %13.919.9 69.8%  
Return on capital %21.431.6 67.6%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m630-   
Fx outflow Rs m4,0670-   
Net fx Rs m-4,0040-   
CASH FLOW
From Operations Rs m3,2883,072 107.0%  
From Investments Rs m-2,496-1,554 160.6%  
From Financial Activity Rs m-826-898 92.0%  
Net Cashflow Rs m-35621 -5.6%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 63.9 75.0 85.2%  
Indian inst/Mut Fund % 7.5 7.9 94.9%  
FIIs % 4.9 0.1 4,900.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 23.7 17.1 138.6%  
Shareholders   85,207 18,270 466.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PFIZER With:   GSK PHARMA  NATCO PHARMA  BIOCON LTD  IPCA LABS  ALKEM LABORATORIES  

Compare PFIZER With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Volatile Day in Red; Pharma Stocks Lose Most(Closing)

After opening the day in green, share markets in India witnessed volatile trading activity throughout the day and ended the day on a negative note.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

After Vakrangee and Manpasand, More Auditors May Soon Resign. To Protect Your Wealth, Avoid these Stocks(The 5 Minute Wrapup)

Jun 8, 2018

The change in auditing regulations can bring a big change in corporate governance behaviour in the mid and small-cap space.

Alert: Pharma Stocks Are About to Shoot Up - And a Superb Stock for Trading(Profit Hunter)

Jun 13, 2018

The ailing pharma stocks are bouncing back to health. Read this to find out the best way to profit from them.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Has the Market Bottomed Out?(Sector Info)

Jun 11, 2018

The yield spread is an effective barometer that can indicate the direction the markets are headed.

Is Data Pointing Towards a Revival in the FMCG Sector?(Sector Info)

Jun 8, 2018

After several quarters of stress in the aftermath of demonetisation and the rollout of GST, this data is pointing towards revival in the India's rural FMCG industry.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

PFIZER SHARE PRICE


Jun 21, 2018 (Close)

TRACK PFIZER

COMPARE PFIZER WITH

MARKET STATS